drugset / Trial / NCT05411861

Post-Operative Pain and Opioid Reduction Trial After Bunionectomy

NCT05411861

Phase 2 Completed 73 enrolled Cali Pharmaceuticals LLC
RandomizedSequentialTriple-blindTreatment

Summary

This is a Phase 2b, randomized, double blind, placebo and active controlled study with an Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing bunionectomy.

Timeline

Start
2022-06-14
Primary completion
2022-09-26
Completion
2022-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CPL-01 Unknown Other
Subject Ropivacaine Other / unclassified Other

Indications

No indication recorded.